• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Pediatrics

Electronic nicotine delivery system marketing associated with subsequent first-time use among youth

byMichael DinhandLeah Carr, MD
August 26, 2019
in Pediatrics, Public Health
Reading Time: 3 mins read
High schoolers use e-cigarettes to vaporize cannabis
Share on FacebookShare on Twitter

1. Youth (middle and high school students) and young adults (college students) who had never used electronic nicotine delivery systems (ENDS) but recalled exposure to ENDS marketing on baseline survey had higher odds of initiating ENDS use at 2.5-year follow-up, compared to those who did not recall marketing exposure.

2. ENDS marketing in retail stores was associated with significantly higher odds of ENDS initiation in both youth and young adults, and TV marketing was associated with significantly higher odds of ENDS initiation in young adults.

Evidence Rating Level: 2 (Good)

Study Rundown: In recent years, ENDS use among youth and young adults has continued to rise. Little is known about the factors that may impact initiation of use, such as industry marketing. In this prospective cohort study, researchers used data from surveys conducted among middle school, high school, and college students in Texas. Participants initially reported never starting ENDS use and researchers measured student recall of exposure to ENDS marketing and subsequent initiation of ENDS use on follow-up. Among middle and high school students, recall of exposure to ENDS marketing in retail stores was associated with twice higher odds of ENDS initiation after 2.5-year follow-up, after adjusting for sociodemographics, other tobacco use, and peer ENDS use. College students who recalled exposure to TV or retail store exposure to ENDS marketing at baseline had significantly higher odds of ENDS initiation compared to those who did not.

These findings are limited by a geographically limited sample and reliance on self-reported data. Furthermore, the outcome measured does not contain information regarding frequency or amount of ENDS use. Nonetheless, the study is strengthened by its large sample and study of a previously underexplored exposure. For physicians, these findings highlight an important risk factor when screening for ENDS initiation and identify an avenue for advocacy to prevent rising ENDS use among youth.

Click to read the study, published today in Pediatrics

RELATED REPORTS

Baseline cannabis use may not be associated with abstinence from vaping

2 Minute Medicine Rewind December 15, 2025

#VisualAbstract: Higher Nicotine Consumption Observed Among Youth with Attention-Deficit-Hyperactivity Disorder

Relevant reading: Exposure to Electronic Cigarette Television Advertisements Among Youth and Young Adults

In-Depth [prospective cohort]: Researchers used survey data from the Tobacco Center of Regulatory Science on Youth and Young Adults, collected from 4711 students enrolled in middle school, high school, and college in Texas who reported never having used ENDS at baseline in 2014. Participants completed surveys every 6 months through the spring of 2017. Surveys measured baseline recall of exposure to ENDS marketing through TV, radio, billboards, retail stores, and internet, as well as sociodemographic covariates. The primary outcome measured was ENDS initiation during the follow-up period. The association between recalled ENDS marketing exposure and ENDS initiation was assessed using logistic regression, with adjustment for sociodemographics, other past-30-day tobacco use, sensation seeking, and peer ENDS use.

Youth who recalled exposure to retail store ENDS marketing had 1.99 times higher odds of ENDS initiation compared to those who did not (adjust odds ratio [aOR] = 1.99; 95% confidence interval [CI] 1.25-3.17). Young adults had higher odds of ENDS initiation if they recalled ENDS marketing exposure via TV (aOR = 1.29; 95%CI 1.03-1.63) and retail stores (aOR = 1.30; 95%CI 1.05-1.61).

Image: PD

©2019 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: electronic cigarettes (e-cigs)electronic nicotine delivery systems (ENDS)nicotinetobacco use
Previous Post

#VisualAbstract: Continuous Anticoagulation and Cold Snare Polypectomy Versus Heparin Bridging and Hot Snare Polypectomy in Patients on Anticoagulants With Subcentimeter Polyps

Next Post

Inpatient intensification of hypertension treatment in older men associated with adverse events

RelatedReports

Systematic review examines benefits and adverse effects of cannabinoid therapy
Chronic Disease

Baseline cannabis use may not be associated with abstinence from vaping

January 13, 2026
Letrozole (Femara) boosts fertility of women with Polycystic Ovarian Syndrome
Weekly Rewinds

2 Minute Medicine Rewind December 15, 2025

December 15, 2025
#VisualAbstract: Higher Nicotine Consumption Observed Among Youth with Attention-Deficit-Hyperactivity Disorder
StudyGraphics

#VisualAbstract: Higher Nicotine Consumption Observed Among Youth with Attention-Deficit-Hyperactivity Disorder

April 16, 2025
Strict tobacco licensing laws linked to reduced adolescent smoking initiation
Chronic Disease

Higher nicotine consumption observed among youth with attention-deficit hyperactivity disorder

May 19, 2025
Next Post
Blood pressure variability associated with cardiovascular disease and mortality

Inpatient intensification of hypertension treatment in older men associated with adverse events

#VisualAbstract: Association of Lifestyle and Genetic Risk With Incidence of Dementia

#VisualAbstract: Association of Lifestyle and Genetic Risk With Incidence of Dementia

Evidence-based interventions for pediatric asthma successfully adapted for community health centers

2 Minute Medicine Rewind August 26, 2019

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Transanastomotic tubes not linked to anastomotic stricture after esophageal atresia repair
  • Artificial intelligence (AI) chatbot reduced depression, anxiety, and eating disorder risk symptoms
  • Real-time AI guidance enters live brain tumor surgery
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.